Astrid Borkowski is Chief Medical Officer at HilleVax, Inc. (HLVX). They have made 5 open-market trades across 1 company since 2023, most recently 2024-02-08.
CIK 0001923461
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HLVX | 161,260 | $337K |
Shares reported on the most recent Form 4, priced at the 2024-02-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HLVX | SELL | 2024-02-08 | 2024-02-12 | $14.93 | $117K | +6.0% | +20.6% | -8.6% |
| HLVX | SELL | 2023-12-15 | 2023-12-18 | $15.50 | $155K | +5.5% | -2.5% | +14.1% |
| HLVX | SELL | 2023-12-01 | 2023-12-05 | $14.35 | $287K | +0.9% | +5.4% | +36.1% |
| HLVX | SELL | 2023-11-17 | 2023-11-20 | $14.00 | $140K | +3.5% | +5.2% | +7.5% |
| HLVX | SELL | 2023-11-08 | 2023-11-13 | $13.00 | $65K | +3.5% | +9.7% | +15.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.